The dermocosmetic firm MartiDerm breaks a new record. The brand has managed to sell more than 300 million ampoules worldwide. For the company, this represents a milestone achieved thanks to more than 70 years of work, innovation, and dedication.
MartiDerm began its journey in 1952, at the Farmacia Martí Tor in Barcelona, with a constant purpose: to develop unique and effective formulas to improve skin health.
In 1989, MartiDerm created the first facial ampoules and marked a before and after in dermocosmetics with a formula that kept the properties of vitamin C and proteoglycans intact.
More than 70 years after its founding, MartiDerm is undergoing a strategic evolution that reinforces science, innovation, and knowledge of the pharmaceutical and medical channels.
Montse Martí, CEO and board member of MartiDerm, explained that they aim to be increasingly close to innovation: "We are immersed in an exciting process that stems from the strength of our history and looks to the future with ambition and focus: consolidating the science that has brought us this far, betting on innovation, and being ever closer to professionals and consumers".
Over the past few years, the company has also been consolidating its position in the international market: almost 50% of its revenue comes from international markets, especially in the main countries of Europe, Asia, and Latin America. In Europe, it continues to strengthen its presence in Spain, Portugal, Italy, and France, adapting its communication to the different audiences in these countries.
MartiDerm expects to build solid and sustainable global growth, reinforcing its leadership in innovation and science. The company states that sustainability will continue to be a fundamental pillar and that it is working to reduce its environmental impact and carbon footprint.